title: Novel anticancer agents and targets: recent advances and future perspectives.
abstract: An urgent need for the discovery of novel anticancer agents is required for the long term therapy of cancer. Large number of novel bio-active and potential anticancer agents are being used in clinical and pre-clinical trials. Although many heterocyclic compounds are already available commercially as anticancer agents, great efforts have been put to identify novel anticancer targets. This review provides an insight of the novel anticancer targets and molecules of the first and final stage of clinical and pre-clinical trials.
authors.affiliation: Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad-382481, Gujarat, India.
authors.forename: Kuldipsinh P
authors.initials: KP
authors.lastname: Barot
authors.forename: Stoyanka
authors.initials: S
authors.lastname: Nikolova
authors.forename: Illiyan
authors.initials: I
authors.lastname: Ivanov
authors.forename: Manjunath D
authors.initials: MD
authors.lastname: Ghate
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents